AIStocks
-
Stop Treating Cramer Calls Like Gospel — Marvell’s Crowded, Bausch Is a Gamble
Fade or Follow? Cramer’s Bullish Take on Marvell — and the Murky Bausch Call When Jim Cramer shouts “buy,” you’ve got two choices: grab a seat on the rocket or start looking for the exit. With Marvell riding the AI wave and Bausch Health limping through its turnaround, blindly following either call isn’t a strategy.…
-
Stop Trading Like a Fan: If You’re Buying MRVL or BHC, Bring a Plan
Jim Cramer says buy Marvell (MRVL) and Bausch Health (BHC). Fine. But blindly following TV calls is how you end up bag-holding someone else’s conviction. If you’re going to play these, you need levels. You need risk control. And you need a plan for when the story cracks. Let’s break it down like a trader,…
-
Don’t Trade Cramer’s Excitement — Trade the Chart
When Jim Cramer blesses a stock on Lightning Round, retail money doesn’t just trickle in — it stampedes. The real question isn’t whether he’s bullish. It’s whether you should fade the pop or ride the wave. Let’s talk Marvell (MRVL) and Bausch Health (BHC). Marvell (MRVL): Don’t Fight the AI Tape — But Don’t Chase…
-
Cramer’s Marvell and Bausch Calls Aren’t Crazy — But Timing Is Everything
When Jim Cramer pounds the table, traders listen. They shouldn’t follow blindly — but they should pay attention. His latest calls? Buy Marvell Technology and Bausch Health. Two very different beasts. One riding the AI chip frenzy. The other crawling out of a debt-heavy pharma mess. So is this actionable alpha — or just good…
You must be logged in to post a comment.